−2.37 MGBP
111.99 M
About VALIRX ORD GBP0.001
Sector
CEO
Suzanne Dilly
Headquarters
Nuneaton
Website
Founded
2000
ISIN
GB00BLH13C52
FIGI
BBG000BD7297
ValiRx Plc is a life science company. It focuses on clinical stage cancer therapeutic development, taking proprietary and novel technology for precision medicines towards commercialization and partnering. Its products include epigenomic analysis and treatment of cancer, as well as the technologies can be also applied in other fields, such as neurology and inflammatory diseases. The Company was founded on January 26, 2000 and is headquartered in Nuneaton, the United Kingdom.
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.
Frequently Asked Questions
The current price of VAL is 3.63 GBX — it hasn't changed in the past 24 hours.
Depending on the exchange, the stock ticker may vary. For instance, on LSE exchange VALIRX ORD GBP0.001 stocks are traded under the ticker VAL.
VALIRX ORD GBP0.001 is going to release the next earnings report on Apr 9, 2024. Keep track of upcoming events with our Earnings Calendar.
Yes, you can track VALIRX ORD GBP0.001 financials in yearly and quarterly reports right on TradingView.
Like other stocks, VAL shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade VALIRX ORD GBP0.001 stock right from TradingView charts — choose your broker and connect to your account.